Skip to content
Politically.com Search all
Menu

Final rule 2025-04978

Nonprescription Drug Product With an Additional Condition for Nonprescription Use

In accordance with the memorandum of January 20, 2025, from the President, entitled "Regulatory Freeze Pending Review," the effective date of the final rule, entitled "Nonprescription Drug Product With an Additional Condition for Nonprescription Use," (ACNU) was delayed until March 21, 2025. Additional time is needed for review; therefore, the delay is extended for an additional 60 days.

Source: FederalRegister.gov API v1Recently refreshed. Last successful refresh: 2026-07-31 22:49:02 UTC.

Source-supplied record

Document details

Document number
2025-04978
Published
Mar 25, 2025
Effective
Dec 26, 2024
Comments close
Not supplied
Federal Register citation
90 FR 13553

Docket identifiers

  • Docket No. FDA-2021-N-0862

CFR references

  • Title 21, part 201
  • Title 21, part 314